Blog
Should Value Investors Buy Mistras Group (MG) Stock?
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop
Is Gold Fields Limited (GFI) Stock Outpacing Its Basic Materials Peers This Year?
For those looking to find strong Basic Materials stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Gold Fields (GFI) one of those stocks right now? A
Why Hologic (HOLX) is a Top Value Stock for the Long-Term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The research service
Are Investors Undervaluing Fox (FOX) Right Now?
Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop
Why Fresenius (FMS) is a Top Value Stock for the Long-Term
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.
The popular research
Should Value Investors Buy Erste Group Bank (EBKDY) Stock?
While the proven Zacks Rank places an emphasis on earnings estimates and estimate revisions to find strong stocks, we also know that investors tend to develop their own individual strategies. With
Envoy Medical, Inc. (COCH) Reports Q3 Loss, Misses Revenue Estimates
Envoy Medical, Inc. (COCH) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to a loss of $0.37 per share a year ago. These
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different
Is FIGS (FIGS) Outperforming Other Retail-Wholesale Stocks This Year?
Investors interested in Retail-Wholesale stocks should always be looking to find the best-performing companies in the group. Is Figs (FIGS) one of those stocks right now? A quick glance at the
Should Value Investors Buy Shore Bancshares (SHBI) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the
Currenc Group Inc. (CURR) Q3 Earnings and Revenues Top Estimates
Currenc Group Inc. (CURR) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of a loss of $0.12 per share. This compares to a loss of $0.13 per share a year
Has H World Group Limited Sponsored ADR (HTHT) Outpaced Other Consumer Discretionary Stocks This Year?
For those looking to find strong Consumer Discretionary stocks, it is prudent to search for companies in the group that are outperforming their peers. Has H World Group (HTHT) been one of those
TELUS Q3 Earnings Down Y/Y, Health & Digital Units Drive Revenues
TELUS Corporation TU reported third-quarter 2025 adjusted earnings per share (EPS) of C$0.24, down from C$0.28 a year ago.
Quarterly total operating revenues remained almost flat year over year at
Axcelis Technologies (ACLS) Just Flashed Golden Cross Signal: Do You Buy?
From a technical perspective, Axcelis Technologies (ACLS) is looking like an interesting pick, as it just reached a key level of support. ACLS recently overtook the 20-day moving average, and this
Pebblebrook Hotel (PEB) Just Flashed Golden Cross Signal: Do You Buy?
From a technical perspective, Pebblebrook Hotel (PEB) is looking like an interesting pick, as it just reached a key level of support. PEB recently overtook the 20-day moving average, and this
Down 20% in 4 Weeks, Here's Why Grand Canyon Education (LOPE) Looks Ripe for a Turnaround
Grand Canyon Education (LOPE) has been beaten down lately with too much selling pressure. While the stock has lost 20.1% over the past four weeks, there is light at the end of the tunnel as it is
James Hardie (JHX) Loses 18.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
James Hardie (JHX) has been beaten down lately with too much selling pressure. While the stock has lost 18.3% over the past four weeks, there is light at the end of the tunnel as it is now in
Akamai Technologies (AKAM) Just Flashed Golden Cross Signal: Do You Buy?
Akamai Technologies (AKAM) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, AKAM broke through the 20-day moving average, which
After Plunging 7.9% in 4 Weeks, Here's Why the Trend Might Reverse for Take-Two (TTWO)
Take-Two Interactive (TTWO) has been on a downward spiral lately with significant selling pressure. After declining 7.9% over the past four weeks, the stock looks well positioned for a trend
Howard Hughes Holdings (HHH) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Howard Hughes Holdings (HHH) reported $390.24 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 19.3%. EPS of $2.02 for the same period compares to
Is Vertiv (VRT) a Buy as Wall Street Analysts Look Optimistic?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts
EVgo (EVGO) Reports Q3 Earnings: What Key Metrics Have to Say
EVgo Inc. (EVGO) reported $92.3 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 36.7%. EPS of -$0.09 for the same period compares to -$0.11 a year
Pebblebrook Hotel (PEB) Recently Broke Out Above the 200-Day Moving Average
Pebblebrook Hotel (PEB) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, PEB crossed above the 200-day moving average
Wall Street Bulls Look Optimistic About Axon (AXON): Should You Buy?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts
Kamada (KMDA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
For the quarter ended September 2025, Kamada (KMDA) reported revenue of $47.01 million, up 12.6% over the same period last year. EPS came in at $0.09, compared to $0.07 in the year-ago quarter.
The


